TENS in Scleroderma
NCT: NCT06646913 · COMPLETED
Brief Summary
The goal of this pilot study is to assess the acceptability of the transcutaneous electrical acustimulation (TEA) device in treating Scleroderma-related gastroparesis. The main objective is: To evaluate the acceptability of TEA as an intervention for alleviating symptoms of distension and bloating in individuals diagnosed with Scleroderma. Participants will be provided with the TEA devices that will be applied to the skin for a total of 45 minutes twice daily after meals. Participants will be asked to fill out both daily diaries and biweekly questionnaires to assess for improvement in the gastroparesis symptoms. Participants will also be asked to complete the daily diaries in addition weekly questionnaires during a 4 week post-treatment follow-up period.
Frequently Asked Questions
What is TENS in Scleroderma?
TENS in Scleroderma is a clinical trial registered under NCT06646913. Current status: COMPLETED.
What is the status of NCT06646913?
The current status of NCT06646913 (TENS in Scleroderma) is: COMPLETED.
When did TENS in Scleroderma start?
TENS in Scleroderma started on 2024-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.